A client with Atrial Fibrillation is to undergo a TEE (Transesophageal Echocardiogram). The nurse knows the primary reason for this test is to:

Transesophageal echocardiography (TEE) is used in clients with atrial fibrillation primarily to detect thrombi (clots) in the left atrium, particularly within the left atrial appendage. Because atrial fibrillation causes loss of coordinated atrial contraction, blood can pool and form clots in the left atrial appendage — an area that is poorly visualized by transthoracic echocardiography but is clearly seen with TEE due to its proximity to the esophagus. This is critical before cardioversion, because restoring a normal rhythm in a client who has an existing clot could cause the clot to embolize and result in stroke or other thromboembolic events. Measuring blood pressure accurately is done non-invasively or via arterial line and is not an indication for TEE. Monitoring for pulmonary edema is accomplished through chest X-ray, clinical assessment, and BNP levels, not echocardiography. Measuring liver size is performed using abdominal ultrasound or CT, not a cardiac imaging procedure. The critical clinical judgment principle here is that TEE directly impacts the safety of cardioversion — if a clot is found, anticoagulation must be therapeutic for at least three to four weeks before cardioversion is attempted, or the clot must be confirmed absent before proceeding.